CHNA
Loncar China BioPharma ETF
Set alert
13.53 USD 0.00 0.00%
13.53 Day range 14.30
9.77 52-week range 22.89
- Open
- 14.30
- Prev close
- 13.53
- Mkt cap
- 0
- Vol
- 9
- Avg vol
- 534
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.53
- High
- 14.30
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 14.01
- 200-d avg
- 16.85
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 14.01
- 200-day average
- 16.85
About Loncar China BioPharma ETF
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
News
- CI Global Asset Management Announces Special Reinvested Distribution for CI ICBCUBS S&P China 500 Index ETF (CHNA.B)
- CI Global Asset Management Announces Special Reinvested Distribution for CI ICBCUBS S&P China 500 Index ETF (CHNA.B)
- CI Global Asset Management Announces Risk Rating Change for CI ICBCCS S&P China 500 Index ETF
- Enter The Dragon: Parsing Lunar New Year Opportunities Among Emerging Markets
- Why China May Need To Do More To Boost Investor Confidence
- China Begins Year Of The Dragon With Weak Economic Momentum
- China Growth Could Slow Amid Limited Policy Options
- China Outlook: Market Rescue Welcomed, But More Needed
- Restarting China's Economic Growth
- China Canary Warns About Global Economy And The Downside To Euphoria
Your note
Sign in to keep a note on CHNA — it syncs with the Stock Master app.